Rotator Cuff Repair

Published results showed procedural factors were the most significant drivers of operative costs in arthroscopic rotator cuff repair, while no correlation was found with patient-level factors besides lower charges with women.

According to published results, greater than 35% of patients who undergo rotator cuff repair are unable to return to their previous work level after the procedure.

Reconstruction of massive rotator cuff tears with an acellular dermal matrix allograft yielded better patient-reported outcomes and a lower retear rate compared with rotator cuff repair, according to results.

The value of an acromioplasty, or subacromial decompression, is controversial and currently not supported as routine or essential for value-based care to manage impingement syndrome or rotator cuff disease symptoms.

Surgeons have performed acromioplasty to reduce pain and prevent rotator cuff disease progression since the 1970s. However, in the past decade, a number of randomized trials have brought the appropriate use of acromioplasty into question.

Patients who received ibuprofen required less opiate medication 1 week after arthroscopic rotator cuff repair, but had similar pain scores at 6 weeks compared with patients who received placebo, according to a recent study.

In the 1990s, with advancements in technology and greater patient demand, physicians began to shift from performing surgical procedures in a hospital or ASC to an office-based setting.

Use of perioperative acetaminophen significantly decreased overall opioid consumption and improved pain control following arthroscopic rotator cuff repair, according to results.

Monday 30 November 2020 | 19:00-20:00 Central European Time (CET)

Patients who underwent delayed rotator cuff repair beyond 12 months of diagnosis had an increased risk of undergoing subsequent revision rotator cuff repair, according to results.